Filler around the eyes: the rare complication worth understanding first
Most tear trough filler passes without incident. The reason I still want you to read this is that the eye area is the one part of the face where a rare complication is a sight problem rather than a cosmetic one.
- The arteries around the eye connect back to the artery that supplies the eye itself, which is why this area is treated with more caution than a cheek or a lip.
- Serious complications are genuinely rare. A systematic review of nearly 4,000 patients recorded no vascular events at all, so this is about informed consent, not about avoiding treatment.
- The warning signs are immediate: sudden pain out of proportion, skin turning white or blotchy, or any change in vision during or just after an injection.
- Hyaluronidase, the enzyme used to dissolve filler, only works on hyaluronic acid fillers. It does nothing to permanent or semi-permanent products.
- A bluish shadow appearing weeks after treatment is usually the Tyndall effect from filler sitting too superficially, and it can be dissolved.
I have a professional interest in this subject that goes beyond opinion. Two of the case series I presented at the Asia Pacific oculoplastic meeting in 2024 were about filler in exactly this region: one on correcting under eye hollowing with filler across different age groups, and one on managing an overfilled tear trough with hyaluronidase and controlled re-injection. So this is not an argument against filler. It is the conversation I would want someone to have with you before a needle goes near your eye.
Let me put the risk in proportion first, because the internet does not. A systematic review of filler safety covering nearly four thousand patients recorded no vascular occlusions and no vision loss at all. Most treatments in most hands are uneventful. What follows is not a warning that this is dangerous. It is an explanation of why this particular square of the face is treated with more respect than a cheek.
Why is the eye area treated differently from the rest of the face?
Because the arteries here are branches of the artery that supplies the eye itself. The forehead, the inner brow and the bridge of the nose are fed by the supratrochlear, supraorbital and dorsal nasal arteries, and all three are branches of the ophthalmic artery. The ophthalmic artery also supplies the retina, the light sensitive tissue that makes sight possible. Elsewhere on the face, the arterial supply drains away from the eye. Here, it connects back toward it.
That connection is why injectors talk about pressure and volume in this region the way they do not elsewhere. If filler enters one of those vessels while being pushed, it can travel backwards against the flow, and when the pressure is released it can be carried forward again into the vessels of the eye. That is the mechanism behind the rare reports of vision loss after facial filler, and it is a plumbing problem rather than an allergy or a reaction.
- 1Brow position. A brow that has dropped over time can push down on the upper lid and add to a heavy look.
- 2Upper lid skin and hooding. Loose skin on the upper lid can rest low, sometimes down to the lash line.
- 3Upper lid crease. The fold where the upper lid skin meets the moving part of the lid, which can sit higher, lower, or become less defined with age.
- 4Outer corner lines. Fine lines at the outer corner reflect skin quality rather than the shape of the lid itself.
- 5Lower lid fat bulge. A rounded, outward bulge under the lower lid, formed by fat pushing forward. It is convex, standing proud of the surrounding skin.
- 6Tear trough hollow. A hollow running down and inward from the inner corner, just below the bulge. It is concave, a dip rather than a swelling, which is why it looks shadowed next to the bulge beside it.
How rare is this, honestly?
Rare enough that most injectors will never see it, and serious enough that every injector should have a plan for it. A review published in 2024 gathered every case of blindness from aesthetic injectables reported in the literature over more than a century and found a cumulative total in the hundreds, worldwide, across all injectors and all products. Set against the millions of treatments performed each year, that is a very small number. Dr Ong Jin Khang, who injects this region routinely at The Retreat Clinic, sets out the wider pattern of dermal filler risk beyond the eye in more detail than belongs in a piece written from the surgical side.
Where the reported cases cluster is worth knowing. The nose, the forehead and the glabella between the brows account for most of them, with the tear trough also represented. Fat transfer carries a higher reported risk than hyaluronic acid filler. Recovery is the sobering part: across the pooled cases, complete recovery of vision was uncommon, and the level of vision at the moment of onset was the strongest predictor of the outcome. That is precisely why the response has to be immediate rather than considered.
What are the warning signs, and what should happen next?
Sudden pain out of proportion to the procedure, skin turning white or developing a blotchy net-like pattern, and any change in vision. Those three, during or shortly after an injection, mean the injection stops immediately.
What should happen next is not observation. United Kingdom consensus guidance published for exactly this scenario is clear that the response is urgent and multi-step: stop, assess, give high dose hyaluronidase if the product is hyaluronic acid and a competent clinician is present, and transfer immediately to an emergency department or emergency eye service. Not to a general practice, not to a follow up appointment tomorrow. The window in which retinal tissue survives without blood flow is measured in minutes to a couple of hours, which is why the destination matters as much as the treatment.
If you are reading this having just had treatment and something feels wrong, stop reading and get to an emergency eye service.
What is hyaluronidase, and why should I care which filler I had?
Hyaluronidase is an enzyme that dissolves hyaluronic acid, and it only works on hyaluronic acid. That single fact should shape your choice of product in this region. If a hyaluronic acid filler is placed badly, sits too superficially, migrates, overfills, or enters the wrong place, there is an antidote. If a calcium hydroxylapatite, poly-L-lactic acid or permanent product is placed badly near the eye, there is not, and the options narrow considerably.
This is also why I ask patients to know the name of what was injected, not just the category. In the overfilled tear trough case I presented, the correction depended on knowing the product, dissolving in a controlled way rather than all at once, and then re-treating deliberately afterwards. You cannot plan that without the information.
Why has my under eye area turned bluish weeks later?
That is usually the Tyndall effect, and it is a placement issue rather than a bruise. The skin of the lower lid is the thinnest on the body. When hyaluronic acid sits very close to the surface underneath it, light scattering through the gel makes the area read as blue or grey. People describe it as looking more tired after treatment intended to fix looking tired, which is a particularly frustrating outcome.
It does not fade the way a bruise does, because nothing is resolving. It is corrected by dissolving the filler, and the improvement usually shows within a day. The reason it happens here and not on a cheek is anatomical, and it is the same reason I keep saying this region behaves differently. If the underlying problem was a hollow rather than a bulge in the first place, the piece on tear trough hollowing and how it differs from eye bags explains why filler suits some faces here and not others, and the wider map of what an eye bag actually is covers the cases where filler is the wrong tool entirely.
What should I ask before booking?
Four questions, and none of them are rude. What product are you using, and can it be dissolved, a question that only makes sense once you understand what a dermal filler actually is and how it is meant to behave in the tissue. What is your training specifically in the anatomy of this area. What happens, step by step, if my vision changes during treatment. Where would you send me, and how quickly.
A clinic that answers those readily is showing you its safety culture rather than describing it. Good practice around the eye looks like conservative volumes, deliberate placement, keeping hyaluronidase on the premises with staff who know the protocol, and being willing to say that a particular face is not suited to filler in this region. The clinic I work most closely with on the skin side, The Retreat Clinic, sets out its own view of the five different problems that live under the eye and which of them injection can and cannot solve, which is the same distinction I make in clinic. Where the honest answer is neither filler nor surgery, the piece on what non-surgical eyelid treatment can and cannot do sets out the limits plainly.
When is the problem under your eye not a cosmetic problem at all?
When it is asymmetric, progressive, or accompanied by anything the eye itself is doing. Puffiness that is new and one sided, an eye that looks more prominent than it did in photographs a year ago, a lid that has started to droop, double vision, or a change in the white of the eye showing above the iris: none of those are ageing, and none of them are improved by filler.
Thyroid eye disease in particular is mistaken for tired looking eyes often enough that I include it in every discussion of periorbital appearance, and a droopy lid can occasionally be the first sign of a neurological problem that needs investigating rather than concealing. Any reputable aesthetic clinic will stop and refer when it sees these, which is the correct instinct. If you are not sure which category you are in, the fuller map of what actually makes eyes look tired is the place to start, and the aesthetics section sets out where surgery, injection and skin treatment each honestly belong.
- Chow KM, Khoo WC, Ong JK. Management of Overfilled Syndrome: A Case Report of Successful Correction Using Hyaluronidase and Controlled Re-Injection. APSOPRS 2024 (poster). See her research
- Chow KM, Khoo WC, Ong JK. Non-Surgical Eyebag Correction Using Dermal Filler Injections Across Different Age Groups: A Case Series. APSOPRS 2024 (poster). See her research
- Any change in vision, including blurring, a dark patch, or loss of vision in one eye. Do not wait to see if it settles.
- Sudden severe pain during or immediately after injection, particularly pain that seems out of proportion to the procedure.
- Skin that turns white, or develops a blotchy purple or net-like pattern, around the injected area or on the nose or forehead.
- A drooping eyelid with a pupil that has changed size, or new double vision.
Questions patients ask
For most people it is uneventful. A systematic review covering nearly 4,000 patients found no vascular occlusions or vision loss. The reason the eye area still gets extra caution is not that problems are common, but that the arteries here connect back toward the eye, so the rare complication is a serious one.
The arteries supplying the forehead, the bridge of the nose and the inner eye area are branches of the ophthalmic artery, which also supplies the retina. If filler enters one of these vessels under pressure it can travel backwards and then forwards into the vessels of the eye, blocking blood flow. This is why injection technique and anatomical knowledge matter so much in this region.
In published cases of vision loss, the nose, the forehead and the glabella between the brows account for most reports, with the tear trough also implicated. Fat transfer carries a higher reported risk than hyaluronic acid filler.
Hyaluronidase is an enzyme that breaks down hyaluronic acid. If your filler is hyaluronic acid, it can be dissolved, which is the single most useful safety feature of that class of product. It has no effect on calcium hydroxylapatite, poly-L-lactic acid or permanent fillers, so knowing exactly what was injected is not a trivial detail.
That is usually the Tyndall effect. When hyaluronic acid sits too close to the surface in thin skin, light scatters through it and the area reads as blue or grey rather than filled. It is not a bruise and it will not simply fade. It is corrected by dissolving the filler, and the improvement is usually visible within a day.
Ask what product is being used and whether it can be dissolved. Ask what the plan is if your vision changes during treatment, and where you would be sent. Ask about the injector's specific training in the anatomy of this area. A clinic that welcomes those questions is telling you something useful.
Vision-threatening events need emergency care immediately, which means the nearest emergency eye service rather than travelling to a particular person. For the non-urgent problems, lumps, Tyndall, overfilling and asymmetry, an assessment that includes the eyelid and orbit is useful, and dissolving is often part of the answer.
Sources
- American Academy of Ophthalmology, EyeNet: Safety update on periocular dermal fillers
- Update on blindness from filler, a century of published cases (Aesthetic Surgery Journal)
- UK consensus guidelines: management of filler-induced vision loss
- Safety and complications of facial fillers, systematic literature review
- NHS: Choosing who will do your cosmetic procedure
General information written by a consultant oculoplastic surgeon. It does not replace an examination. If you are worried about your eyes or eyelids, please see an eye doctor. Written and reviewed by Dr Catherine Chow, Consultant Ophthalmologist and Oculoplastic Surgeon, MMC number to follow · NSR 143681.
Bring the midnight questions.
Researching quietly is smart. When you're ready to ask out loud, book a consultation at Eagle Eye Centre Malaysia.
Consultations from early 2027